[Industry Voice #21] ACM Biosciences erklärt Impfstoffentwicklung

In light of ACM Biolabs's recent breakthrough and the efficacy of its COVID-19 vaccine against delta and #omicron variants, we interviewed Alexander Breidenbach, its Chief Development Officer on the overall challenges and intricacies of vaccine research and its role in preventing infectious diseases.

Thank you for your request!
Our team will respond to you within 24 hours.